{"id":"559073-6855","orgnr":"559073-6855","name":"Buzzard Pharmaceuticals AB","name_registered_on":"2016-10-17","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2016-08-24","business_description":"Bolaget ska bedriva forskning, utveckling och kommersialisering av läkemedel och därmed förenlig verksamhet.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"}],"postal_address":{"city":"STOCKHOLM","country":"SE","municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"active","employee_class":{"code":"2","name":"1-4 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K3","signed_on":"2026-06-15","documents":{"annual_report":"/v1/documents/72d4ad12-29b6-4ee9-9545-ad6a268a67a3.xhtml","audit_report":"/v1/documents/9f08d0ca-c429-42a7-815c-bc095a415872.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/25_6.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K3","signed_on":"2025-06-25","documents":{"annual_report":"/v1/documents/bab4e286-1982-4312-861c-9b3c28fc8848.xhtml","audit_report":"/v1/documents/86431adb-9058-4039-a1ac-a5fbe82f64ab.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/26_9.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K3","signed_on":"2024-06-28","documents":{"annual_report":"/v1/documents/f35c0bc2-b9ab-495d-8873-c6c7c0eb31e0.xhtml","audit_report":"/v1/documents/fcf74c76-8260-4816-bca1-b4e721d0fa16.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/26_9.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":0,"other_operating_income":5120,"operating_profit":-3831707,"profit_after_financial_items":-3805775,"net_profit":-3805775,"total_assets":137996606,"current_assets":4286816,"equity":136114525,"share_capital":70705,"unrestricted_equity":4227584,"current_liabilities":1882081,"cash":2999214,"staff_costs":1249386,"source":{"annual_report":"2025-12-31","document":"/v1/documents/72d4ad12-29b6-4ee9-9545-ad6a268a67a3.xhtml"},"anchors":{"cash":{"text":"2 999 214"},"current_assets":{"text":"4 286 816"},"current_liabilities":{"text":"1 882 081"},"equity":{"text":"136 114 525","prefix":"775"},"net_sales":{"text":"0","prefix":"Nettoomsättning"},"operating_profit":{"text":"3 831 707"},"other_operating_income":{"text":"5 120"},"profit_after_financial_items":{"text":"3 805 775","suffix":"-657"},"share_capital":{"text":"70 705","prefix":"utgång"},"staff_costs":{"text":"1 249 386"},"total_assets":{"text":"137 996 606","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"4 227 584","prefix":"775"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-06-15","signatories":[{"name":"U*****","role":"Ordförande"},{"name":"C*****"},{"name":"G*****"},{"name":"M*****","role":"Verkställande direktör"}],"auditors":[{"name":"C*****","title":"Auktoriserad revisor","firm":"Crowe Osborne AB"}]}}